Skip to main content

Pharmacokinetic Nanoparticles

The group of design and pharmacodynamics of nanoparticles at the Vall d’Hebron Research Institute focuses on the synthesis, characterization, and applications of engineered inorganic nanoparticles in the field of medicine. By mastering the inorganic core (size, structure, and shape) and understanding and controlling the linking of molecules to the nanoparticle surface, we engineer nanoparticles that can interact with biological systems in a specific way. We also put particular emphasis on safety, feasibility, scale-up, applicability, and other aspects of nanoparticle design.

Our group is led by Prof. Víctor Puntes, who holds an ICREA Research Professorship. Since a great part of our work demands highly multidisciplinary expertise, we maintain several strong collaborations with biologists, immunologists, oncologists, physicists, environmentalists, and more, from all over Europe, China and the US. The work of the group has resulted in several patents and the creation of several spin-offs such as Nanotargeting and Applied nanoparticles.

Team

Victor Franco Puntes

Victor Franco Puntes

Head of group
Pharmacokinetic Nanoparticles
Read more
Victor Franco Puntes

Victor Franco Puntes

Head of group
Pharmacokinetic Nanoparticles
Read more

Projects

A new formulation of cerium oxide nanoparticles as adjuvant for retinal anti-angiogenesis therapy.

IP: Victor Franco Puntes
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 150000
Reference: 2023 PROD 00200
Duration: 01/02/2024 - 31/10/2025

Nanopartícules farmacocinètiques

IP: Victor Franco Puntes
Collaborators: Ramon Gonzalez Rioja, Joana Ramis Garcia
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 00878
Duration: 01/01/2022 - 30/06/2025

NEW ANTIOXIDANT STRATEGIES FOR THE MULTIMODAL TREATMENT OF PREECLAMPSIA (AFRODITA)

IP: Elena Carreras Moratonas
Collaborators: Itziar Garcia Ruiz, Erika Bonacina, Joana Ramis Garcia
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI20/00606
Duration: 01/01/2021 - 30/06/2025